Hobbs, Richard
University of Oxford
8 papers on CoChatORCID 0000-0001-7976-7172
Most cited papers
- Verified
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal
Health Promotion and Cardiovascular PreventionClinical practice guidelines implementation
Cited by 8,490
- Verified
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)
Endorsed by the Association for European Paediatric Cardiology (AEPC), Authors/Task Force Members, Baumgartner, H., Bonhoeffer, P., De Groot, N. M. S., de Haan, F., Deanfield, J. E., Galie, N., Gatzoulis, M. A., Gohlke-Baerwolf, C., et al. (2010) · European Heart Journal
Congenital Heart Disease StudiesCardiovascular and Diving-Related Complications
Cited by 2,331
- Verified
Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)
Developed in collaboration with, European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), and Heart Rhythm Society (HRS), societies, E. B. T. F., European Society of Emergency Medicine (EuSEM), European Federation of Internal Medicine (EFIM), European Union Geriatric Medicine Society (EUGMS), American Geriatrics Society (AGS), European Neurological Society (ENS), et al. (2009) · European Heart Journal
Cardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic Control
Cited by 2,040
- Verified · note
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 706
- Verified
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
Williams, B., MacDonald, T. M., Morant, S. V., Webb, D. J., Sever, P., McInnes, G. T., Ford, I., Cruickshank, J. K., Caulfield, M. J., Padmanabhan, S., et al. (2018) · The Lancet Diabetes & Endocrinology
Hormonal Regulation and HypertensionBlood Pressure and Hypertension Studies
Cited by 347
- Verified
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 192
- Verified
A systematic review and thematic synthesis of qualitative studies exploring GPs' and nurses' perspectives on discussing weight with patients with overweight and obesity in primary care
Warr, W., Aveyard, P., Albury, C., Nicholson, B., Tudor, K., Hobbs, R., Roberts, N., & Ziebland, S. (2021) · Obesity Reviews
Obesity and Health PracticesPatient-Provider Communication in Healthcare
Cited by 102
- Verified
Randomised controlled feasibility trial of a web-based weight management intervention with nurse support for obese patients in primary care
Yardley, L., Ware, L. J., Smith, E. R., Williams, S., Bradbury, K. J., Arden-Close, E. J., Mullee, M. A., Moore, M. V., Peacock, J. L., Lean, M. E., et al. (2014) · International Journal of Behavioral Nutrition and Physical Activity
Mobile Health and mHealth ApplicationsObesity and Health Practices
Cited by 84
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free